Hellgren Margareta, Hjörleifsdottir Steiner Kristin, Bennet Louise
Department of Public Health and Community Medicine/Primary Health Care, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Neurobiology, Care Sciences and Society, Division of Family Medicine, Karolinska Institutet, Alfred Nobels allé 23, 141 83 Huddinge, Sweden.
Prim Care Diabetes. 2017 Aug;11(4):337-343. doi: 10.1016/j.pcd.2017.04.008. Epub 2017 May 22.
To explore and compare sensitivity and specificity for HbA1c ≥48mmol/mol as a predictor for type 2 diabetes mellitus (T2DM) in two populations with different ethnicity and to examine the predictive value of two levels of HbA1c (≥42mmol/mol, ≥39mmol/mol) for prediabetes in these populations.
Four cohorts were examined with an oral glucose tolerance test. (1) The MEDIM Study (n=1991 individuals of Swedish and Iraqi ancestry); (2) The Skaraborg Project (n=1327 individuals of Swedish ancestry); (3) The 4-D study (n=424 individuals of Swedish, Iraqi and Turkish ancestry); (4) The Flemingsberg study (n=212 participants of Turkish ancestry).
HbA1c ≥48mmol/mol had a sensitivity for T2DM of 31% and 25% respectively in individuals of Middle-East and Swedish ancestry. The positive and negative predictive value was high in both populations (70.3, 96.4 and 96.2, 97.6 respectively). Using HbA1c ≥42mmol/mol and ≥39mmol/mol as a predictor for prediabetes gave a sensitivity of 17% and 36% in individuals of Middle-East and 15% and 34% in individuals of Swedish ancestry.
Even if HbA1c ≥48mmol/mol is a valuable diagnostic tool, it is a blunt and insensitive tool for screening and would exclude most people with T2DM, independent of ancestry and age. HbA1c is an inefficient way to detect individuals with prediabetes.
探讨并比较糖化血红蛋白(HbA1c)≥48mmol/mol作为预测2型糖尿病(T2DM)指标时在两个不同种族人群中的敏感性和特异性,并检验两个HbA1c水平(≥42mmol/mol、≥39mmol/mol)对这些人群糖尿病前期的预测价值。
对四个队列进行口服葡萄糖耐量试验检查。(1)MEDIM研究(1991名瑞典和伊拉克裔个体);(2)斯卡罗堡项目(1327名瑞典裔个体);(3)4-D研究(424名瑞典、伊拉克和土耳其裔个体);(4)弗莱明斯贝里研究(212名土耳其裔参与者)。
在中东裔和瑞典裔个体中,HbA1c≥48mmol/mol对T2DM的敏感性分别为31%和25%。两个群体的阳性和阴性预测值均较高(分别为70.3、96.4和96.2、97.6)。将HbA1c≥42mmol/mol和≥39mmol/mol作为糖尿病前期的预测指标时,中东裔个体的敏感性分别为17%和36%,瑞典裔个体的敏感性分别为15%和34%。
即使HbA1c≥48mmol/mol是一种有价值的诊断工具,但它作为筛查工具却不够精确且不敏感,会排除大多数T2DM患者,且与种族和年龄无关。HbA1c是检测糖尿病前期个体的低效方法。